Sunshine Book Value Per Share from 2010 to 2025

SBFMW Stock

USD 0.20 0.01 4.76%

Sunshine Biopharma Book Value Per Share yearly trend continues to be fairly stable with very little volatility. Book Value Per Share is likely to outpace its year average in 2025. Book Value Per Share is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of Sunshine Biopharma Warrant according to its financial statements. View All Fundamentals

Book Value Per Share

First Reported

2010-12-31

Previous Quarter

1.6 K

Current Value

1.6 K

Quarterly Volatility

1 K

Credit Downgrade

Yuan Drop

Covid

Check Sunshine Biopharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sunshine Biopharma's main balance sheet or income statement drivers, such as Interest Expense of 148.9 K, Other Operating Expenses of 34.9 M or Total Operating Expenses of 15.8 M, as well as many indicators such as Price To Sales Ratio of 0.3, Dividend Yield of 0.0 or PTB Ratio of 0.34. Sunshine financial statements analysis is a perfect complement when working with Sunshine Biopharma Valuation or Volatility modules.

Check out the analysis of Sunshine Biopharma Correlation against competitors.

For more information on how to buy Sunshine Stock please use our How to Invest in Sunshine Biopharma guide.

Latest Sunshine Biopharma's Book Value Per Share Growth Pattern

Below is the plot of the Book Value Per Share of Sunshine Biopharma Warrant over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. Sunshine Biopharma's Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sunshine Biopharma's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 12.52 X

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Book Value Per Share

Timeline

Sunshine Book Value Per Share Regression Statistics

	Arithmetic Mean	376.56
	Geometric Mean	118.87
	Coefficient Of Variation	271.24
	Mean Deviation	787.87
	Median	27.42
	Standard Deviation	1,021
	Sample Variance	1M
	Range	4K
	R-Value	0.59
	Mean Square Error	731,346
	R-Squared	0.35
	Significance	0.02
	Slope	126.14
	Total Sum of Squares	15.6M

Sunshine Book Value Per Share History

	2025	1647.43
	2024	1568.98
	2023	1743.31
	2022	2849.48
	2021	162.07
	2020	-1102.58
	2019	-416.65

Other Fundumenentals of Sunshine Biopharma

Tangible Book Value Per Share

Sunshine Biopharma Book Value Per Share component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Common Stock	Short Term Debt	Net Receivables	Intangible Assets	Net Tangible Assets	Property Plant Equipment	Current Deferred Revenue	Long Term Debt	Good Will	Net Invested Capital	Short Long Term Debt	Capital Stock	Net Working Capital	Short Term Investments
Total Assets		1.0	-0.98	-0.94	1.0	0.98	1.0	-0.31	0.21	0.99	0.78	0.78	-0.78	0.61	0.77	-0.68	1.0	0.9	-0.58	1.0	-0.68
Total Stockholder Equity	1.0		-0.98	-0.92	1.0	0.97	1.0	-0.31	0.17	0.99	0.78	0.78	-0.75	0.58	0.75	-0.68	1.0	0.88	-0.6	1.0	-0.68
Net Debt	-0.98	-0.98		0.93	-0.98	-0.96	-0.98	0.32	-0.28	-0.95	-0.73	-0.77	0.75	-0.6	-0.77	0.53	-0.99	-0.86	0.6	-0.98	0.53
Retained Earnings	-0.94	-0.92	0.93		-0.93	-0.97	-0.94	0.24	-0.36	-0.91	-0.81	-0.81	0.91	-0.78	-0.9	0.52	-0.93	-0.93	0.49	-0.94	0.52
Accounts Payable	1.0	1.0	-0.98	-0.93		0.98	1.0	-0.31	0.2	0.99	0.78	0.77	-0.77	0.6	0.75	-0.67	1.0	0.88	-0.58	1.0	-0.67
Total Liab	0.98	0.97	-0.96	-0.97	0.98		0.98	-0.28	0.35	0.95	0.75	0.78	-0.85	0.7	0.82	-0.63	0.98	0.91	-0.49	0.98	-0.63
Total Current Assets	1.0	1.0	-0.98	-0.94	1.0	0.98		-0.31	0.22	0.98	0.77	0.78	-0.78	0.62	0.77	-0.67	1.0	0.9	-0.57	1.0	-0.67
Common Stock	-0.31	-0.31	0.32	0.24	-0.31	-0.28	-0.31		-0.06	-0.3	-0.12	-0.38	0.36	-0.31	-0.36	0.18	-0.3	-0.36	0.31	-0.31	0.18
Short Term Debt	0.21	0.17	-0.28	-0.36	0.2	0.35	0.22	-0.06		0.06	-0.14	0.3	-0.41	0.41	0.43	0.21	0.25	0.31	-0.08	0.21	0.21
Net Receivables	0.99	0.99	-0.95	-0.91	0.99	0.95	0.98	-0.3	0.06		0.83	0.76	-0.75	0.57	0.73	-0.73	0.98	0.88	-0.57	0.99	-0.73
Intangible Assets	0.78	0.78	-0.73	-0.81	0.78	0.75	0.77	-0.12	-0.14	0.83		0.63	-0.69	0.64	0.75	-0.5	0.75	0.73	-0.41	0.78	-0.5
Net Tangible Assets	0.78	0.78	-0.77	-0.81	0.77	0.78	0.78	-0.38	0.3	0.76	0.63		-0.7	0.46	0.73	-0.48	0.78	0.87	-0.72	0.79	-0.48
Property Plant Equipment	-0.78	-0.75	0.75	0.91	-0.77	-0.85	-0.78	0.36	-0.41	-0.75	-0.69	-0.7		-0.92	-0.94	0.48	-0.77	-0.9	0.26	-0.79	0.48
Current Deferred Revenue	0.61	0.58	-0.6	-0.78	0.6	0.7	0.62	-0.31	0.41	0.57	0.64	0.46	-0.92		0.92	-0.25	0.6	0.73	-0.13	0.63	-0.25
Long Term Debt	0.77	0.75	-0.77	-0.9	0.75	0.82	0.77	-0.36	0.43	0.73	0.75	0.73	-0.94	0.92		-0.33	0.76	0.9	-0.39	0.79	-0.33
Good Will	-0.68	-0.68	0.53	0.52	-0.67	-0.63	-0.67	0.18	0.21	-0.73	-0.5	-0.48	0.48	-0.25	-0.33		-0.65	-0.62	0.36	-0.68	1.0
Net Invested Capital	1.0	1.0	-0.99	-0.93	1.0	0.98	1.0	-0.3	0.25	0.98	0.75	0.78	-0.77	0.6	0.76	-0.65		0.89	-0.58	1.0	-0.65
Short Long Term Debt	0.9	0.88	-0.86	-0.93	0.88	0.91	0.9	-0.36	0.31	0.88	0.73	0.87	-0.9	0.73	0.9	-0.62	0.89		-0.54	0.91	-0.62
Capital Stock	-0.58	-0.6	0.6	0.49	-0.58	-0.49	-0.57	0.31	-0.08	-0.57	-0.41	-0.72	0.26	-0.13	-0.39	0.36	-0.58	-0.54		-0.58	0.36
Net Working Capital	1.0	1.0	-0.98	-0.94	1.0	0.98	1.0	-0.31	0.21	0.99	0.78	0.79	-0.79	0.63	0.79	-0.68	1.0	0.91	-0.58		-0.68
Short Term Investments	-0.68	-0.68	0.53	0.52	-0.67	-0.63	-0.67	0.18	0.21	-0.73	-0.5	-0.48	0.48	-0.25	-0.33	1.0	-0.65	-0.62	0.36	-0.68

Click cells to compare fundamentals

About Sunshine Biopharma Financial Statements

Sunshine Biopharma investors use historical fundamental indicators, such as Sunshine Biopharma's Book Value Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Sunshine Biopharma. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Book Value Per Share	1.6 K	1.6 K
Tangible Book Value Per Share	1.5 K	1.5 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

MSFT	Microsoft
V	Visa Class A
C	Citigroup

Additional Tools for Sunshine Stock Analysis

When running Sunshine Biopharma's price analysis, check to measure Sunshine Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sunshine Biopharma is operating at the current time. Most of Sunshine Biopharma's value examination focuses on studying past and present price action to predict the probability of Sunshine Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sunshine Biopharma's price. Additionally, you may evaluate how the addition of Sunshine Biopharma to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC